Bad news here.
The SEC is slow but they will discover the lawbreakers behind the fall in valuation.
SEC & NASDAQ is a bunch of clones that do little to protect the investor. Time to call NASDAQ & SEC.
Exec's at CLDX should be laughed, except they took millions in corporate funds as compensation.
I hope exec's at CLDX see time in the pokey.
CLDX is in his taget and getting popped.
Don't feel bad if the big boys get hoodwinked us retail buyers are due what we get too. Funny how market is killing this stock....
They won't even enforce their own regulations. Market is populated and regulated by fraudsters.
NASDAQ should require all short sellers to prove existence of "borrowed" share.
CLDX is in deep financial woes and 02/22/2016 will likely shed light on their cash burn rate and inability to raise future capital. They will be sold.
CLDX has too many shares available and tomorrow may be a repeat. Bad decision to have so so many share outstanding.
I also have an income producing property located between two boroughs in an eastern state. How much am I bid. CLDX won't exist to commercially market their product. They will run out of cash in 18 months
Really interesting not one press release. Who provides their crisis management? Daffy Duck?
CLDX must have so very well placed enemies that wish it would disappear. Marucci is getting crushed personally with about 1,200,000 shares owed of CLDX. Couldn't happen to a better guy.
The oversight committee of NASDAQ does nothing to enforce naked shorting of a stock. Why do you ask?
Because it's composed of brokers who make their living out of taking advantage of common shareholders.
Mutual funds and private equity funds have about as many ethics as congress.
Celldex Therapeutics is drawing bearish option activity ahead of quarterly results next month.
optionMONSTER's Depth Charge monitoring program shows that 5,400 March 7 puts were purchased for $0.80 to $0.85 today. This represents fresh buying, as open interest in the strike was only 45 contracts before the trades appeared.
Long puts lock in the price where a stock can be sold, so they make money to the downside. Investors use them to hedge long positions or to speculate on a drop.(See our Coaching section)
CLDX is down 8.82 to $8.75 near the final hour of trade and has dropped 42 percent in the last month. The biopharmaceutical company is expected to report earnings in pre-market hours on Feb. 24, about 3-1/2 weeks before today's puts expire.
Overall option volume in the name is 3 times greater than average today, according to the Depth Charge
CLDX is getting gored must be really glum at company when you know nobody believes your CEO is an honest person and you CFO liquidated as many shares as possible at much higher prices. It must really smell all around CLDX.